- BCI’s net income for the fourth quarter was CLP 170.46 billion, slightly exceeding estimates of CLP 168.87 billion.
- Net income decreased by 5.6% compared to the same period last year.
- The total loans issued by BCI grew by 11% year over year, reaching CLP 55.56 trillion.
- BCI’s total assets increased by 7.3% from the previous year, amounting to CLP 83.42 trillion.
- Return on average equity dropped to 12.2% from 13.1% in the previous year.
- BCI shares experienced a 2.7% rise, closing at CLP 30,300 with 70,557 shares traded.
- Analyst recommendations for BCI included 6 buys, 3 holds, and 1 sell.
A look at Banco De Credito E Inversion Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking ahead, Banco De Credito E Inversion shows a promising long-term outlook based on the Smartkarma Smart Scores. With a robust Growth score of 4 and a solid Momentum score of 4, the company is positioned well for expansion and market performance. Additionally, earning an average score of 3 in both Value and Dividend categories indicates a fair valuation and potential for dividend payouts to investors. However, the lower Resilience score of 2 suggests some vulnerability to economic fluctuations.
Banco De Credito E Inversion, commonly known as BCI, is a financial institution focused on attracting deposits and providing a range of banking services, including credit cards, insurance, and brokerage services. With a balanced mix of growth potential and market momentum, the company appears well-positioned for future opportunities and investor interest, despite facing some resilience challenges. Investors may find BCI to be an intriguing prospect with its overall positive indicators in key areas.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
